24小时热门版块排行榜

返回列表

当前主题已经存档。

zlwcw

木虫 (著名写手)

应助: 1 (幼儿园)
金币: 2021.1
散金: 225
红花: 8
帖子: 1274
在线: 219.7小时
虫号: 530429
注册: 2008-03-21
性别: GG
专业: 代谢性疾病药物药理

[交流] 【其他】NATURE---Lessons from 60 years of pharmaceutical innovation_Nature_Munos

Abstract | Despite unprecedented investment in pharmaceutical research and development
(R&D), the number of new drugs approved by the US Food and Drug Administration (FDA)
remains low. To help understand this conundrum, this article investigates the record of
pharmaceutical innovation by analysing data on the companies that introduced the
~1,200 new drugs that have been approved by the FDA since 1950. This analysis shows that
the new-drug output from pharmaceutical companies in this period has essentially been
constant, and remains so despite the attempts to increase it. This suggests that, contrary to
common perception, the new-drug output is not depressed, but may simply reflect the
limitations of the current R&D model. The implications of these findings and options to
achieve sustainability for the pharmaceutical industry are discussed.

回复此楼

» 猜你喜欢

1楼2010-03-18 16:05:22

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

相关版块跳转我要订阅楼主 zlwcw 的主题更新

返回列表